We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$82.7M
2
PEP icon
PepsiCo
PEP
+$76.8M
3
MAR icon
Marriott International
MAR
+$64.8M
4
TSN icon
Tyson Foods
TSN
+$62.8M
5
PARA
Paramount Global Class B
PARA
+$52.9M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFG icon
1751
American Financial Group
AFG
$11.9B
$13K ﹤0.01%
180
– –
CNX icon
1752
CNX Resources
CNX
$4.85B
$13K ﹤0.01%
859
+71
+9% +$1.05K
ICL icon
1753
ICL Group
ICL
$6.81B
$13K ﹤0.01%
3,553
+688
+24% +$2.79K
JHX icon
1754
James Hardie Industries
JHX
$15.4B
$13K ﹤0.01%
840
-161
-16% -$2.62K
KOF icon
1755
Coca-Cola Femsa
KOF
$21.6B
$13K ﹤0.01%
182
– –
ACH
1756
Accendra Health
ACH
$240M
$13K ﹤0.01%
405
-125
-24% -$4.38K
ORA icon
1757
Ormat Technologies
ORA
$6.11B
$13K ﹤0.01%
280
– –
PBR icon
1758
Petrobras
PBR
$121B
$13K ﹤0.01%
1,415
– –
RJF icon
1759
Raymond James Financial
RJF
$32.5B
$13K ﹤0.01%
345
– –
SSL icon
1760
Sasol
SSL
$7.58B
$13K ﹤0.01%
520
-76
-13% -$2.05K
THC icon
1761
Tenet Healthcare
THC
$20.1B
$13K ﹤0.01%
647
+83
+15% +$2.16K
VIV icon
1762
Telefônica Brasil
VIV
$22.4B
$13K ﹤0.01%
1,011
– –
WFC.PRL icon
1763
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$13K ﹤0.01%
10
– –
WIT icon
1764
Wipro
WIT
$18.5B
$13K ﹤0.01%
7,403
– –
GNMK
1765
DELISTED
GenMark Diagnostics, Inc
GNMK
$13K ﹤0.01%
1,103
+103
+10% +$994
AXE
1766
DELISTED
Anixter International Inc
AXE
$13K ﹤0.01%
211
+15
+8% +$903
WBC
1767
DELISTED
WABCO HOLDINGS INC.
WBC
$13K ﹤0.01%
120
– –
GWR
1768
DELISTED
Genesee & Wyoming Inc.
GWR
$13K ﹤0.01%
195
– –
BML.PRI.CL
1769
DELISTED
Bank Of America Corporation
BML.PRI.CL
$13K ﹤0.01%
509
– –
OSHC
1770
DELISTED
Ocean Shore Holding Co.
OSHC
$13K ﹤0.01%
600
– –
VEDL
1771
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$13K ﹤0.01%
1,371
– –
MDVN
1772
DELISTED
MEDIVATION, INC.
MDVN
$13K ﹤0.01%
178
-42
-19% -$2.97K
VXX
1773
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$13K ﹤0.01%
99
– –
AVNT icon
1774
Avient
AVNT
$3.45B
$12K ﹤0.01%
375
-10
-3% -$346
BBD icon
1775
Banco Bradesco
BBD
$38.1B
$12K ﹤0.01%
2,804
– –
69 70
71
72 73

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.